Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Faculty of Anesthesiology, Changhai Hospital, Shanghai, Shanghai, China
Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of
Sherief Abd-Elsalam, Tanta, Egypt
Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil
Department of Anesthesiology and Critical Care Medicine - University Hospital of Nancy, Nancy, France
Michigan Medicine - University of Michigan, Ann Arbor, Michigan, United States
Beijing Tian Tan Hospital, Beijing, China
Akademiska sjukhuset, Centraloperation, Uppsala, Sweden
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.